Clin2
NCT06661382Possibly a fitRecruiting

Cord blood plasma vs placebo for vulvar lichen sclerosus

Vulvar Lichen Sclerosus

Part of Women’s health & pregnancy clinical trials.

This study tests whether a shot of concentrated healing cells from umbilical cord blood (called platelet-rich plasma) can help treat vulvar lichen sclerosus better than a placebo shot. It aims to find a new, safe option for women who are not helped by standard treatments.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
100 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are a woman with vulvar lichen sclerosus (diagnosed by a doctor or a biopsy).
  • You are in generally good health and able to give written consent to participate.
  • You are not pregnant or planning to become pregnant.
  • You do not have bleeding disorders, platelet problems, or serious heart or lung disease.
  • You do not have a current serious infection, and you have not had previous surgery on your vulva (like fat grafting or PRP).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07240389Not yet recruiting
New treatments for vulvar lichen sclerosus

This trial compares three treatments for vulvar lichen sclerosus: a steroid ointment, a non-steroid ointment, and platelet-rich plasma therapy. It aims to see which works best for managing symptoms and improving skin health.

Krakow, Małopolska
NCT07363733Recruiting
Comparing radiofrequency vs steroid cream for vulvar lichen sclerosus

This study compares a new non-invasive treatment using radiofrequency energy to a standard steroid cream for women with vulvar lichen sclerosus. The goal is to see which works better for symptom relief.

Moscow
NCT06662942Recruiting· Phase 1
Testing StrataMGT for vulvar lichen sclerosus symptoms

This study tests whether a new topical treatment, StrataMGT, can reduce symptoms of vulvar lichen sclerosus. It is for women with moderate to severe symptoms who are already using a stable topical prescription.

Washington D.C., District of Columbia
NCT07240519Recruiting
Comparing clobetasol cream vs CO2 laser for vulvar lichen sclerosus

This study compares two treatments—clobetasol steroid cream or a fractional CO2 laser—for women with vulvar lichen sclerosus who have not used steroid cream before. It looks at how inflammation changes after treatment.

Rio de Janeiro, Rio de Janeiro
NCT07450625Not yet recruiting
Collagendep for vulvar dryness after fat grafting

This study tests whether a supplement called Collagendep can help reduce vulvar dryness in people with lichen sclerosus who are already receiving a fat grafting procedure. It aims to see if adding the supplement improves comfort and symptoms.

NCT06135402Recruiting
Laser vs. cream for vulvar lichen sclerosus

This study tests if laser therapy works as well as clobetasol cream for vulvar lichen sclerosus after a previous course of the cream. It aims to offer an alternative treatment option for people who have already completed the standard cream therapy.

Winterthur, Canton of Zurich

Hear when a new Vulvar Lichen Sclerosus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.